Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ALLO-605 |
Trade Name | |
Synonyms | ALLO 605|ALLO605 |
Drug Descriptions |
ALLO-605 are allogeneic T-cells engineered to express a BCMA targeting chimeric antigen receptor (CAR), with TRAC and CD52 gene inactivation, which may lead to antitumor activity (Blood (2020) 136 (Supplement 1): 8). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C182066 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ALLO-605 | ALLO-605 | 0 | 0 |
ALLO-605 + ALLO-647 + Cyclophosphamide + Fludarabine | ALLO-605 ALLO-647 Cyclophosphamide Fludarabine | 0 | 1 |